Canopy Growth Intends to Dominate in Canada and then Expand Internationally

Visit the Canopy Growth Corp Investor Dashboard and stay up to date with data-driven, fact based due diligence for active traders and investors.

Canopy Growth CEO Bruce Linton

James Midas interviewed Canopy Growth (CVE: CGC) CEO Bruce Linton, covering a wide variety of topics over the fourteen minutes:

  • Snoop Dogg deal was in the works for almost 2 years
  • Branding now complete, with Bedrocan for medical and Tweed heading towards adult-use
  • LCBO is the likely model
  • $5 Bedrocan pricing allows company to “share the pain” with patients managing pain
  • Tweed is focused on unique strains to produce price differentiation
  • Oils are coming
  • Greenhouse in Niagara now using 27% of 350K s.f.
  • 30% sequential patient count growth is goal
  • M&A is possible
  • U.S. not really an option for now due to federal laws, but company expects to operate in other countries within next three years

Read the transcript or listen to “Canopy Growth Corp CEO Bruce Linton On Tweed’s Deal With Snoop Dog”: http://www.midasletter.com/2016/02/canopy-growth-corp-cve-cgc-snoop-dog-otcmkts-twmjf-mmpr-medical-marijuana/

The most reliable, fact-based information on Canopy Growth Corp. found only on its Investor Dashboard.

Get ahead of the crowd by signing up for 420 Investor, the largest & most comprehensive premium subscription service for cannabis traders and investors since 2013.

Published by NCV Newswire
NCV Newswire
The NCV Newswire by New Cannabis Ventures aims to curate high quality content and information about leading cannabis companies to help our readers filter out the noise and to stay on top of the most important cannabis business news. The NCV Newswire is hand-curated by an editor and not automated in anyway. Have a confidential news tip? Get in touch.

Get Our Sunday Newsletter